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Hypoxia is a typical hallmark of many solid tumors and often leads to therapy resistance and 
the development of a more aggressive cancer phenotype. Oxygen content in tissues has been 
evaluated using numerous different methods for several imaging modalities, but none has yet 
reached the required standard of spatial and temporal resolution. Magnetic Resonance 
Imaging (MRI) appears to be the technique of choice and several pO2-responsive probes have 
been designed for it over the years. In vivo translation is often hampered in Gd-relaxation 
agents as it is not possible to separate effects that arise from changes in local concentration 
from those associated with responsive properties. A novel procedure for the MRI based 
assessment of hypoxia is reported herein. The method relies on the combined use of Gd-
DOTP- and Gd-HPDO3A-labeled-Red Blood Cells (RBCs) where the first probe acts as a 
vascular oxygenation-responsive agent, while the second reports the local labeled RBC 
concentration in a transplanted breast tumor mouse model. The MRI assessment of 
oxygenation state has been validated by photoacoustic imaging and ex vivo 
immunofluorescence. The method refines tumor staging in preclinical models and paves the 
















Hypoxia is one of the main tumor hallmarks and a characteristic feature of advanced solid 
tumors and results from an imbalance between oxygen supply and consumption.
1,2 
In fact, 
tumor growth is often accompanied by heterogeneous vascular system growth leading to 
insufficient blood supply in some tumor regions, as oxygen’s maximum diffusion distance is 
70-150 m, so generating chronic hypoxia. Furthermore, intratumoral vascular networks are 
not well organized in cancers and severe structural and functional abnormalities are found. 
These include the formation of a chaotic architecture, which is characterized by an increase in 
vessels with an elongated and tortuous shape, the absence of flow regulation, intermittent 
stasis, high endothelial permeability and a lack of specific receptors. All these phenomena can 
lead to acute ischemic hypoxia, which is often transient.
3 
The absence of sufficient 
oxygenation (either chronic or acute) can reduce the effectiveness of medical therapies. 
Radiotherapy, photodynamic therapy and many chemotherapeutic drugs which act on cell 
proliferation are active in well oxygenated regions, but have been found to lack efficiency 
when tissue oxygen pressure (pO2) is low.
4 
Furthermore, cancer cells that lack sufficient O2 
show changes in gene expression and gene regulation pathways, leading to an alteration in the 
tumor cell proteome which permanently modifies cancer cell metabolism and aggressiveness.
5
 
The hostile environment triggers the selection and clonal expansion of more aggressive cancer 
cells that are able to survive in low or nil oxygen and nutrient supply conditions, thus 
generating a new cancer phenotype which is more aggressive and resistant to treatment.
6
 The 
ability to assess hypoxia levels is central to cancer diagnosis and therapy for these reasons.
7,8
 
A direct measurement of pO2 can be done using sensitive electrodes but this is not feasible in 
many cases.
9,10
 Despite being able to provide a rapid and direct pO2 measure, the resulting 










internal organs cannot be reached, which limits the method to use on superficial cancers.
9,10
  
One of the “hot topics” in cancer research at present is the development of an imaging 
procedure that is able to determine pO2 in the tumor region. Various imaging modalities, 
including optical, photoacoustic, MRI and nuclear imaging, have been used to develop 
protocols for the detection of tumor hypoxia over the last few decades. Optical imaging is 
widely used in this field for the ex-vivo characterization of tumor biopsies and for some 
preclinical in vivo studies. Several fluorescent probes, whose fluorescence is strongly 
quenched in the presence of O2, have been proposed. However, a lack of penetration into in-
depth regions is still a problem that strongly limits in vivo application to superficial cancers.
11
 
Progress has been made with recent developments in photoacoustic imaging (PAI) as it allows 
operators to selectively acquire images of oxy- and deoxy-Hemoglobin (Hb) thus providing 
detailed information on oxygenation state at greater depths than optical imaging.
12
 As far as 
human applications are concerned, the gold standard is still nuclear medicine with 
Nitroimidazole (
18
F-MISO) and other markers which are reduced in a hypoxic environment to 
yield species that are trapped inside hypoxic cells. Unfortunately, nuclear imaging’s 
intrinsically low resolution has hampered pO2-responsive tracers in clinical settings to some 
extent.
13,14 
 Meanwhile, MRI has been the focus of a great deal of attention as it combines 
well contrasted images of soft tissues, high in-depth penetration and a lack of ionizing 
radiation. Moreover, its high spatio-temporal resolution is all important when attempting to 
identify hypoxic and normoxic regions inside a tumor. Chemistry has also been playing an 
important role as it has developed innovative MRI contrast agents (CAs) which are able to 
detect parameters of physio/pathological interest for the characterization of both healthy and 
diseased tissues.
15,16  










applications rely on the use of the Blood Oxygen Level Depended (BOLD) approach.
17,18  
This technique makes it possible to distinguish paramagnetic deoxy-Hb from diamagnetic 
oxy-Hb by observing Signal Intensity (SI) changes in T2*-weighted proton images. One 
limitation is that the SI change is also strongly influenced by Hb concentration, which may be 
the result of a real variation in vascular volume and/or blood flow.
19
 MRI contrast agent 
developers have long looked for new probes that can determine the oxygenation state of the 







 and hyperpolarized agents
23,24
. However, these probes have not yet been 






 upon its binding with oxy- or deoxy-Hb
28,29
 and reported that this molecule 
appeared to be suitable as a hypoxia reporter. In the meantime, new important advances in the 
loading of small molecules inside RBCs have been made and have prompted us to further 
investigate the feasibility of using Gd-DOTP-labeled RBCs for in vivo applications.
30,31,32 
The MRI method that we present herein is based on the combined use of Gd-DOTP- and 
[Gd(10-(2-hydroxypropyl)-1,4,7-tetraazacyclododecane-1,4,7-triacetate] Gd-HPDO3A-
labeled-RBCs, where the first probe acts as a vascular oxygenation-responsive agent and the 
second furnishes local labeled RBC concentration, for the evaluation of hypoxia in a 
transplanted breast tumor mouse model. The significance of this work lies in the possibility of 
developing a protocol that can achieve the high resolution, in vivo evaluation of tumor 
hypoxia in all of the body’s organs. This method may also be of great interest from the 
preclinical point of view as it could be used to evaluate new therapeutic oncology protocols.  










aid in choosing suitable therapy; ineffective, harsh and expensive treatments can be avoided 
when the required tissue oxygenation conditions are not present. 
 
Results and discussion 
 
In vitro Relaxometric characterization of Gd-complexes 
 
Gd-DOTP (Figure 1A) is known to be a probe that can bind Hb. Furthermore, it has been 
proven that it has different binding affinities for the two Hb states; the presence or absence of 
O2 (R and T state, respectively).
25-29
 Its relaxivity increases upon Hb binding, mainly as the 
result of an increase in the rotational correlation time. This property links nicely with the idea 
of its loading inside RBCs to report on pO2 once injected in the blood. In the case of tumors, it 
is expected that the change in SI in the region of interest can be correlated to the actual 
oxygen pressure. The affinity constants (Ka) for the two Hb states were evaluated. Different 
concentrations of Hb, freshly extracted from mouse blood (in the presence of the endogenous 
concentration of 2,3 Biphosphoglycerate- 2,3 BPG), were incubated with Gd-DOTP (0.1mM) 
and the longitudinal relaxation rate (R1=1/T1) measured at 21.5MHz and 25°C (Figure 1B). 
The measured Ka and r1-bound (i.e. the relaxivity of the Gd-complex bound to the 
macromolecule) are reported in Table1. The number of binding sites was fixed at 1 per 
tetramer as previously established.
25-27
 In accordance with a previously reported 
investigation,
25-27
  Gd-DOTP displays high affinity for deoxy-Hb and a lower value for oxy-
Hb (5 times higher for the former than for the latter). The affinity constant for deoxy-Hb 
measured here is slightly lower than the value reported in reference 16 (Ka = 3300 M
-1
) as this 










of 2,3 BPG, which most likely acts as a competitor. The relaxation enhancement achieved is 




, which is more 




).  Gd-DOTP was 
then loaded inside RBCs using Hypotonic Swelling methodology,
33
 i.e. by subjecting the cells 
to an osmotic shock that makes the membrane transiently permeable to the compounds 
present in the incubation medium. A high amount (Figure S1) of Gd-DOTP can be loaded 
inside each cell using Hypotonic Swelling without any appreciable adverse effects (high cell 
recovery after treatment and low hemoglobin release). The relaxometric properties of the Gd-
labeled RBCs were investigated by acquiring Nuclear Magnetic Relaxation Dispersion 
(NMRD) profiles over an extended range of Larmor frequencies (0.01-80 MHz). NMRD 
profiles give a sort of molecular fingerprint of the paramagnetic complex that provides insight 
into the cellular microenvironment and possible relationships with other molecules. The 
profiles were acquired in both normoxia and oxygen deprivation conditions, which were 
obtained by removing O2 from the specimen with the inflow of N2 gas (Figure 1C). The 
occurrence of oxy- or deoxy-Hb was checked by recording a UV-vis Absorption Spectra of 
the samples (Figure S2). A relaxivity peak is present in the NMRD profiles at 30-40 MHz, 
typical of the interaction of the Gd-complex with a slowly moving macromolecule, for both 
Hb states. The relaxivity of labeled RBCs in hypoxic conditions is far higher than in normoxia 
over the entire investigated frequency range because of the higher interaction strength 
between Gd-DOTP and deoxy-Hb. It has been suggested that Gd-DOTP binds the protein at 
the site normally recognized by the allosteric effector 2,3 BPG via an interaction with the 












Gd-HPDO3A (ProHance®, Bracco Imaging Spa, Figure 2A) was chosen to report on the 
local Gd-labeled RBC concentration. This uncharged and hydrophilic Gd-complex is well 
tolerated by cell machinery
 32,34
 and is used here as a contrast molecule that does not bind Hb 
regardless of whether it is in the T or R state. Its binding affinity constant (Ka) is practically 
negligible for both deoxy- and oxy-Hb (Figure 2B and Table1) as the observed increase in 
R1 simply reflects the change in the viscosity of the solution upon increasing the Hb-
concentration. 
The absence of binding to Hb or any other intracellular macromolecules was confirmed via 
the acquisition of Gd-HPDO3A-labeled RBC NMRD profiles. Gd-HPDO3A were efficiently 
loaded inside RBCs via hypotonic swelling (Figure S1) and the Gd-HPDO3A-loaded-RBC 
NMRD profiles did not show any relaxation enhancement at 30-40 MHz (Figure 2C), 
whether in normoxic or hypoxic conditions. The relaxivity was actually lower than the value 
measured in water. This behavior may be ascribed to the well-known relaxivity quenching 
effect that occurs when large numbers of Gd-complexes are loaded inside cells.
35-37
 In 
summary, Gd-HPDO3A-RBCs do not appear to react to changes in pO2, while Gd-DOTP-
RBCs are good reporters of the oxy-Hb/deoxy-Hb ratio. 
 
 O2-binding affinity of  Gd-DOTP-labeled-RBCs 
Photoacoustic images (PAI) were acquired on tumor bearing mice pre and post Gd-DOTP-
RBC administration in order to check whether the loading of RBCs with Gd-DOTP affected 
cell functionality (i.e. O2-binding). In PAI, non-ionizing laser pulses are delivered into 
biological tissues, absorbed by an excitable molecule (such as Hb) and converted into heat. 










used to generate images. The Hb absorption spectrum differs with oxygenation and therefore 
dual-wavelength (750 and 850 nm) PAI acquisition can be used to selectively visualize and 
quantify oxy- and deoxy-Hb. A large number of superficial tissue and subcutaneous 
transplantable tumor applications have been reported for PAI in recent years.
38,39
 PAI allows 
scientists to calculate hemoglobin Oxygen Saturation (SO2), which is defined as the ratio 
between Oxy-Hb and total Hb concentrations (1):  
                                                                                                      (1)                                                                                                                    
  
The in vivo mapping of hypoxia was carried out on tumor transplanted models that were 
obtained via the subcutaneous injection of a murine mammary adenocarcinoma cell line 
(TS/A) into BALB/c mice.
40
 Mean PAI SO2 measurements in the tumor region, acquired both 
before and after Gd-DOTP-RBC administration, rule out the possibility that labeled-RBCs 
have any significant effect on oxygen saturation inside cells (Figure S3), as the pre and post 
SO2 values are not significantly different (Paired Student's t-Test: t(5) = 0.870, p=0.424). 
Analogously, no difference in SO2 was noted upon the administration of Gd-HPDO3A-RBCs 
(data not shown). 
 
 In vivo experimental set-up for vascular oxygenation measurement 
The use of Gd-DOTP-labeled RBCs alone in MRI experiments is not sufficient for the 
determination of oxygenation state in tumor voxels because of the MRI signal’s dependence 
on CA-concentration. Therefore, the two agents (Gd-DOTP- and Gd-HPDO3A-labelled 
RBCSs) were used in combination, where the latter acts as a reporter of the local 










The experimental set-up scheme is shown in Figure 3. It is made up of three steps; i) the 
injection of Gd-HPDO3A- RBCs and MRI acquisition, ii) the injection of Gd-DOTP-RBCs 
and MRI acquisition and iii) the ratiometric analysis of MR images which provided the Signal 
Enhancement  (SE%) ascribable to deoxy-Hb. The T1w images of TS/A tumors acquired upon 
Gd-HPDO3A-RBCs injection were used to give images in which SE does not depend on O2 
content and thus report, voxel by voxel, the vascular volume.
32
 
Conversely, observed SE is dependent on both vascular volume and relative oxy-/deoxy-Hb 
concentration (related to actual SO2 value) in the T1w images of TS/A tumors acquired upon 
Gd-DOTP-RBC injection. The ratio between the two images allows data normalization which 
gives a map where Signal Intensity (SI) is not dependent on actual vascular volume but only 
on oxy- and deoxy-Hb content. The tumor was investigated by acquiring 7 parallel axial slices 
(slice thickness = 1mm) that cover the entire tumor region (Figure 4). Each labeled-RBC 
administration was preceded by the withdrawal of an amount of blood which contained as 
many RBCs as there were labeled RBCs to be injected. This was done to keep the hematocrit 
value constant.  
Representative images obtained upon Gd-HPDO3A-RBC administration are reported in 
Figure 4A. These maps report on vascular volume distribution voxel by voxel. The vascular 
network appears to be heterogeneously distributed within the tumor, although there are some 
poorly vascularized regions. GdDOTP-RBCS were successively (ca. 20 minutes after Gd-
HPDO3A RBC injection) administrated and a new MRI acquisition was carried out. The 
vascular volume in each voxel was normalized which allowed the oxygenation maps to be 
calculated.  The results are reported in Figure 4B. Higher levels of deoxy-Hb are highlighted 










indicate areas of higher oxygenation. It should be noted that deoxy- and oxy-regions are not 
homogeneously distributed in the tumor mass. The internal regions are characterized by a 
strong deoxygenation profile, while the peripheral regions show no sign of hypoxia. An 
average vascularization of 10.6±3.2% and an average relative oxygenation index of 
73.4±8.4% were measured over the entire tumor. The latter index should not be taken as a 
quantitative measure of the oxygen content of the tumor, but rather should be seen as 
qualitative and very useful when comparing different regions within a given tumor as well as 
different stages in tumor progression.  
In Figure 4C (Top: Vascular volume map; Bottom: hypoxia weighted map) it is well evident 
that the hypoxic region is largely dominant in the tumor core. The use of the proposed method 
to evaluate tissue hypoxia relies on the assumption that Hb oxygenation is proportional to 
blood pO2 which, in turn, is in equilibrium with oxygen present in the surrounding tissues. In 
the tumor region, the oxygen tension may be low for two main  reasons, namely i) the tumor 
cells are consuming O2  more rapidly than it can be delivered or ii) the region is necrotic, thus  
there is less delivery because of the reduced vascularization. The latter case is ruled out 
becouse the T2w  image did not show necrosis (Figure 4D) thus the areas showing an increase 





PAI and microscopy validation of MRI results 
PAI of the same mice was carried out in order to validate the MRI results. As shown in 
Figure 5, PAI indicates that the tumor core is more hypoxic than the rim. The different 










Figure 5A (red = highly oxygenated regions; blue = poorly oxygenated regions), and the 
corresponding PA Spectra (Figure 5B). Total Hb distribution in the tumor region is reported 
in Figure S4A. PA images confirm the heterogeneous vascular network distribution that was 
detected by MRI. Moreover, the oxygenation levels that were measured by MRI and PAI over 
the entire tumor are compared in Figure 5C. There is good overall agreement between the 
two sets of measurements (Oxygenation Index (OI) %=73.4±8.4% by MRI vs. 
SO2=68.4±7.5% by PAI, respectively) even if these two values cannot be directly compared 
as they are not defined in the same way. Further insight can be obtained by looking at the 
vascular oxygen content in the different tumor regions (by means of the two imaging 
modalities). Vascular oxygen content has been plotted against distance from the tumor center 
and is reported in Figure S4B; both the techniques highlight a progressive increase in 
oxygenation from the tumor core to the rim. This is in line with expectations that the tumor 
core is poorly oxygenated. Mice were sacrificed after in vivo imaging while the tumors were 
explanted and stained for vessels (CD31) and hypoxia (HIF-1 ) markers. The tumor core is 
characterized by a large hypoxic region (Figure 6, upper insert). Conversely, there are no 
HIF-1  positive regions in the tumor rim (Figure 6, lower insert).  
In order to further explore the potential of the method reported herein, murine breast tumors 
were compared at two different stages of their development; at an early and late stage when 
tumor sizes were 55±5 mm
3
 and 130±10 mm
3
 (i.e. 6 and 9 days after the tumor implantation). 
It is well known that a change in vascular volume and oxygenation occurs during tumor 
growth. MRI shows the non-homogeneous distribution of deoxy- and oxy-regions and of 
vascularised voxels at both tumor stages. An increase in vascular volume was observed upon 










vascular network does not provide enough O2 to the entire tumor mass and the mean 
Oxygenation Index in the tumor decreases in the latter stage tumor (from 95.8±2.5% to 
73.0±6.8%) (Figure S5, S6, Table S1). Both the early and late tumor stage changes in 




In summary, it has been shown that the pO2-responsive properties of Gd-DOTP are 
maintained in vivo when the paramagnetic complex is entrapped in RBCs. Maps that report 
the actual deoxy-Hb/oxy-Hb ratio have been obtained. Gd-labeled RBCs appear to be safe, 
morphological and physiological analogues to native cells, while their complete retention in 
the vascular system means that tumor vascular volume and oxygen content can be evaluated. 
These important cancer hallmarks are strictly linked to disease development and malignance 
degree and their assessment via a high resolution imaging modalities, such as MRI, is 
undoubtedly of interest for characterizing tumor phenotype. In our opinion, both tumor 
staging and treatment follow-up can be greatly improved by evaluating hypoxia with this 
minimally invasive imaging method. Finally, the information on vascular oxygenation level 














Gd-HPDO3A was kindly provided by Bracco Imaging S.p.A (Colleretto Giacosa, Torino, 
Italy).  Gd-DOTP was synthesized as reported elsewhere.
 43
 Fetal Bovine Serum (FBS), 
Roswell Park Memorial Institute-1640 (RPMI-1640) medium, Glutamine, Pen/Strep solution 
and Trypsine were purchased from Lonza Group. Ficoll Hystopaque, heparin and all other 
chemicals were purchased from Sigma-Aldrich Co. LLC.  
 
 
Isolation of RBC and labeling by hypotonic swelling 
Erythrocyte separation was carried out using the Ficoll Hystopaque
1039
 methodology. Blood, 
diluted 1:1 with Phosphate Buffered Saline (PBS), was stratified into Ficoll Hystopaque1039 
and centrifuged for an uninterrupted 30 minutes  at 1500 rpm and 25°C. The pellet 
(containing erythrocytes) was separated from the other components, washed three times with 
Heparin supplemented PBS and centrifuged at 2300 rpm for 10 min and 4°C. The separated 
erythrocytes were later used for uptake experiments.  The labeling was carried out by loading 
the two Gd-complexes using the osmotic swelling methodology. Cells were placed in a 
hypotonic solution (160 mOsm/l) containing the CA to be loaded (Gd-HPDO3A 100 mM or 
20 mM or Gd-DOTP 20mM), at 4 °C for 30 min. The isotonic condition (280 mOsm/l) was 
then restored by adding the necessary amount of phosphate buffer saline (PBS). The 
difference in the concentrations of the two Gd-complexes used depends on the different net 
charge of the two chemicals (5- vs. 0) and thus on the different osmolarities of their solutions. 
The labeled erythrocytes were extensively washed with PBS to remove the non-internalized 
Gd-complexes. The osmolarities of the solutions used were monitored using a manual Löser 










Hemoglobin concentration (HGB), Mean Corpuscolar Volume (MCV), Mean Corpuscolar 
Hemoglobin (MCH), Mean Corpuscolar Hemoglobin Concentration (MCHC) were evaluated 
by Emocromocytometric assay on an automated Model MICROS O.T, Horiba ABX 
Diagnostics haemocytometer and the amount of Hb was evaluated by measuring SORET band 
region absorbance (413 nm) using a 6715 UV-Vis Spectrophotometer Jenway (Bibby 
Scientific Limited, Beacon Road, Stone, Staffordshire, ST15 OSA, UK). 
ICP-MS Measurements of metal content 
The number of RBCs was counted at the end of each experiment using the automatic 
emocromocytometer. Erythrocytes were then destroyed by a strong osmotic shock. Briefly, 
distillate water was added to the RBC samples (1:50 v/v) to give an external osmolarity of ca. 
60 mOsm/l and samples were agitated to help the lyses. 1ml of concentrated HNO3 (70%) was 
then added to 100 l of each sample which were digested by microwave heating (Milestone 
MicroSYNTH, Microwave lab station equipped with an optical fiber temperature control and 
HPR-1000/6M six position high-pressure reactor, Bergamo, Italy).  After digestion, the 
volume of each sample was brought to 2 ml with ultrapure water, filtered on a 0.4 m filter 
and analyzed by ICP-MS, using a Thermo Scientific ELEMENT 2 ICP-MS -Finnigan, 
Rodano (MI). Three replicates of each sample solution were analyzed.  The specimens then 
underwent ICP-MS analysis to measure the Fe and Gd concentrations.  
 
Depriving samples of oxygen  
RBCs specimens and Hb solutions were used at normal oxygen pressure (normoxia) and in an 
oxygen deprived condition (hypoxia), which was obtained by loading the sample in a 5-mm 










the specimens by PE-tube to obtain a complete O2-remotion.  The experimental method was 
tested by observing oxy- and deoxy-Hb amounts via the acquisition of Absorbance Spectra on 
a 6715 UV-Vis Spectrophotometer Jenway (Bibby Scientific Limited, Beacon Road, Stone, 
Staffordshire, ST15 OSA, UK). Oxy-Hb has two peaks at 541 nm and 576 nm, while deoxy-




H-relaxometric measurements, NMRD profiles and Proton Relaxation Enhancement 
(PRE) procedure. 
 The longitudinal water proton relaxation rate was measured on a Stelar Spinmaster (Stelar, 
Mede, Pavia, Italy) spectrometer operating at 21.5 MHz, by means of the standard inversion-
recovery technique. The relaxometric characterization of the field-dependent relaxometry of 
the Gd-loaded RBCs was achieved using 
1
H-NMRD profiles. The proton 1/T1 NMRD profiles 
were measured on a fast field-cycling Stelar Relaxometer over a continuum of magnetic field 
strengths from 0.00024 to 0.47 T (corresponding to 0.01-20 MHz proton Larmor frequencies). 
Additional data points in the 20-70 MHz range were obtained on a Stelar Spinmaster 
spectrometer. The binding parameters (affinity constant KA, number of equivalent and 
independent binding sites n and the relaxivity of supramolecular adduct Gd-complex/Hb) 
were determined using the proton relaxation enhancement (PRE) method. The method 
consists in measuring the R1 of a Gd complex solution at a fixed concentration by increasing 
the concentration of the macromolecule. The fitting of the obtained curve furnishes the Ka and 
R1
bound
 values. The paramagnetic contribution to the observed relaxation rate of hemoglobin in 










by plotting the observed relaxation rate of Hb suspensions at different concentrations vs their 
ICP-MS measured iron content.  
 
Animal handing 
Six to ten week-old female BALB/c mice (Charles River Laboratories Italia s.r.l., Calco, Italy) 
were subcutaneously inoculated in the left flank with 0.1 ml of a single suspension containing 
5×10
5
 TS/A mouse breast cancer cells. TS/A cells were grown in a RPMI medium 
supplemented with 10 % FBS, 2 mM glutamine, 100 U/ml penicillin and 100 µg/ml 
streptomycin. Mice were kept in standard housing in a 12 h light/dark cycle with rodent chow 
and water available ad libitum. Experiments were performed according to national regulations 
and were approved by the local animal experiment ethical committee. Mice were anesthetized 
for the MRI experiments by the intramuscular injection of a mixture of Tiletamine/Zolazepam 
(Zoletil 100, Virbac, Milan, Italy) 20 mg/kg and xylazine (Rompun; Bayer, Milan, Italy) 5 
mg/kg. The Gd-labeled RBCs were prepared as described above and injected into the mouse 
tail vein at a dose of ca. 0.04 mmoles Gd/Kg.  
The safety profile of the Gd-labeled RBCs was qualitatively investigated. No immunological 
reaction was present as the RBCs used for the transfusion were obtained from syngeneic 
donor mice. Moreover, in order to avoid hypervolemia, a volume of blood, which 
corresponded to the volume of labeled blood that was to be injected, was removed from the 
receiving mouse before the administration of the transfusion. Furthermore, the mice were 













MRI experiments  
All MR images were acquired at 7.1 T on a Bruker Avance 300 MHz spectrometer equipped 
with a microimaging probe at room temperature (21 °C).  T2-weighted images were acquired 
using a standard T2- weighted  Rapid Acquisition with Relaxation Enhancement (RARE)  
sequence with the following parameters (TR= 5000 ms, TE= 5.5 ms, RARE factor= 32, 
FOV=3.5 cm x 3.5 cm, slice thickness = 1 mm , matrix 128 x 128). T1-weighted images were 
acquired using a standard T1- weighted Multi Slice Multi Echo (MSME) sequence with the 
following parameters (TR =200 ms, TE=3.3ms, number of average =4, FOV=3.5cm x 3.5cm, 
slice thickness = 1 mm, matrix 128x128, resolution 0.273x0.273 mm/pixel). In order to 
eliminate the flow artifact, axial saturation slices were applied close to the region of 
acquisition with the following parameters; slice thickness 20mm, Hermitian shape pulse, 
length 1ms, Flip Angle of 90°. A glass tube containing water as reference was inserted close to 
the mouse body.  
 
Image analysis  
 Tumor volume was determined using multislice T2w images. A Region of Interest (ROI) was 
manually drawn and the slice volume was calculated. The T1w images with the saturation 
slices were processed using ImageJ software (NIH, USA).  The T1 contrast enhancement 
(S
post
) in the ROI upon Gd-DOTP-RBC injection was calculated with respect to the signal 
measured before Gd-RBC injection (S
pre
) using the following expression (2):   















carried out on one of the main blood vessels in which the flow artifact T1 signal was removed 
by the saturation slices. The ROI was chosen inside the veins where total Hemoglobin is 
expected to be in the deoxygenated state (3). 





 were normalized with respect to same external reference as before. 
The Ratio (RGdDOTP) between the SE inside the tumor voxels and the mean SE in the vein was 
calculated according to the following expression (4):  
                                                                                                                 (4) 
The images acquired upon Gd-HPDO3A-RBC administration were analogously analyzed and 
the Ratio (RGdHPDO3A) between SE inside the tumor voxels and the mean SE in the main vessel 
was calculated according to the following expression (5): 
                                                                                                          (5) 
The obtained maps report on Vascular Volume (Vv) voxel per voxel.  
The images obtained upon Gd-DOTP-RBC and Gd-HPDO3A-RBC administration were 
combined as follows (6), in order to obtain normalized maps that report the oxygenation state 
independently from the actual vessel density in the voxel: 
                                                                                 (6) 
A relative Oxygenation Index (OI%) was calculated from this value as follows (7): 
 












Mice were sacrificed after MRI and PAI acquisition and TS/A-derived tumors were explanted. 
Tumors were washed twice in PBS (Sigma-Aldrich, Milano, Italy) and embedded in Optimal 
Cutting Temperature compound (OCT, from Bio-Optica, Milano, Italy) prior to being frozen. 
3 m thick sections were cut with a microtome-cryostat along the entire tumor and two 
equivalent series of glass slides were prepared. Sections were acetone fixed for 10 minutes at 
room temperature, rinsed twice in PBS and immediately blocked in PBS + Bovin Serum 
Albumin (BSA) 10% for 30 min at room temperature. Slices were then incubated overnight 
with mouse anti-HIF1α (Santa Cruz, Santa Cruz California) and rat anti-CD31 (BD 
Pharmingen, Milan, Italy) primary antibodies. After extensive washes in PBS 10% BSA, 
sections were incubated for 1h at room temperature with Alexa Fluor 568 goat anti-rat and 
Alexa Fluor 488 goat anti-mouse secondary antibodies, both from Life Technologies 
(Carlsbad, CA). Glasses were then washed again, incubated with DAPI (DakoCytomation) for 
15 minutes at room temperature and mounted in Faramount aqueous mounting medium 
(Sigma-Aldrich). Images were acquired using an ApoTome system equipped with AxioVision 
Release 4.8 software (Zeiss, Germany). 
 
 
Photoacoustic detection of vascular volume 
PA (photoacoustic) images were acquired using a VisualSonics Vevo 2100 LAZR Imaging 
Station (VisualSonics, Inc., Toronto, Canada). Hair was removed from areas of interest using 










at high resolution, B-mode imaging was acquired using a high-frequency ultrasound probe 
(MS550D, VisualSonics, Canada, broadband frequency: 22 MHz - 55MHz, image axial 
resolution: 40 um) at 40 MHz.  Oxygen saturation and hemoglobin concentration were 
measured at 21 MHz frequency (LZ250, VisualSonics, Canada). Hb content was measured 
with a laser set at 812 nm. Oxygen saturation (SO2 %) was measured with PA dual-
wavelength imaging at 750 and 850 nm. All PA images were co-registered with grey scale B-
mode images.  The quantification of total hemoglobin and oxygen saturation was achieved 
using HemoMeaZure™ tool and OxyZated™ tool (VisualSonics, Canada), respectively.  
 
Statistical Analysis 
Data are represented as mean±SD. A paired two-tail Student’s t-test was used in the 
comparison of PAI data in the pre and post Gd-DOTP-RBC administration experiment and in 
the comparison of MRI data in the early and late stage tumor progression experiment.  
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Figure 1. Gd-DOTP characterization. A) Chemical Structure of Gd-DOTP; B) Relaxometric 
Titration of Gd-DOTP with oxy- or deoxy-Hb (Mean±SD); C) NMRD profiles of Gd-DOTP-















Figure 2. Gd-HPDO3A characterization A) Chemical Structure of Gd-HPDO3A; B) 
Relaxometric Titration of Gd-HPDO3A with oxy- or deoxy-Hb (Mean±SD); C) NMRD 















Figure 3. Illustrative scheme of the experimental set-up. RBCs taken from the mouse are 










vein and MRI Vascular Volume (Vv) maps are acquired. Then Gd-DOTP-RBCs are injected 
into the same mouse and T1w maps are acquired. The ratio between these two maps allowed us 














(A) Vascular Volume maps of 7 slices covering the tumor; (B) relative deoxygenation maps 
of 7 slices covering the tumor; (C) Magnification of Vascular Volume (top) and relative 











Figure 5. (A) PA image of central tumor slice showing hypoxic (blue) and normoxic (red) 














Figure 6. Immunofluorescence staining. Fluorescence image of a representative central 
slice of TS/A tumor reported in Fig. 5. IF staining for CD31 (red) and HIF-1a (green). Nuclei 
were counterstained with DAPI (blue). Upper IF image is taken from tumor core; lower IF 


















Table 1. Values of the binding parameters of Gd-DOTP and Gd-HPDo3A toward oxy-Hb and 















 1823±253 88±6.5 
rb oxy Hb (s
-1
) 22.9±10.5 n.a. 
rb de-oxy Hb (s
-1
) 37.5±1.77 n.a. 
Ratio 







































Gd-DOTP-labeled and Gd-HPDO3A-labeled- RBCs can be efficiently employed as 
innovative MRI agents that re able to measure hypoxia and vascular volume in the tumor 
region using MRI.  Gd-loaded-RBCs, thanks to their high biocompatibility, are an efficient 
and safe system with which to evaluate, in vivo, these physiological parameters that are at the 
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